News und Analysen
![QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test: https://mms.businesswire.com/media/20240401748874/en/2086245/5/1542601_QV_UC_COVID-19_2T_Angle01.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd3BvYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9ae16133c13a2fc034c0b726b0fe6e0e20fc38ab/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/1542601_QV_UC_COVID-19_2T_Angle01.jpg?locale=de)
QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho" or the “Company”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its QuickVue COVID-19 test. This clearance allows
![STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024: https://mms.businesswire.com/media/20240402599401/en/2086323/5/Image_1_STAAR_Will-Levis-Invite_1x1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDluYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fa23ec2e21217d7c32cef570a2369591bed90f85/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Image_1_STAAR_Will-Levis-Invite_1x1.jpg?locale=de)
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, astigmatism and presbyopia, comes to
EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
![Should You Buy This Blue Chip Stock's Dip Hand Over Fist?: https://g.foolcdn.com/editorial/images/770902/medical-technician.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM3RuYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--28f75adfb500f072b2f5ff92c093e1a812b65bae/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/medical-technician.jpg?locale=de)
Should You Buy This Blue Chip Stock's Dip Hand Over Fist?
Cyberattacks can disrupt corporations, and you've seen that play out in recent weeks. UnitedHealth Group (NYSE: UNH) fell roughly $14 billion behind in paying claims after a hacker group attacked
![Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance: https://g.foolcdn.com/editorial/images/771135/two-people-use-devices-at-home-getty.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK3RsYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--713f509427575145b70b70821370683510026abd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/two-people-use-devices-at-home-getty.jpg?locale=de)
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
If you're an everyday investor looking for stocks that can deliver steadily rising dividend payouts over long periods, the healthcare sector is the right place to begin your search. People get sick
![This Beleaguered Ultra-High-Yield Dividend Stock Might Soon Get Some Much-Needed Relief: https://g.foolcdn.com/editorial/images/770905/a-person-making-financial-calculations.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOEZsYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d15f5bf2fa4a3ecf8b54ad78a3a01c223afccbf0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-person-making-financial-calculations.jpg?locale=de)
This Beleaguered Ultra-High-Yield Dividend Stock Might Soon Get Some Much-Needed Relief
Medical Properties Trust (NYSE: MPW) has fallen on hard times over the past few years. Shares of the hospital-focused real estate investment trust (REIT) have lost more than 80% of their value from
EQS-News: Resolutions of the Annual General Meeting of Sartorius AG
EQS-News: RHÖN-KLINIKUM AG looks back on successful financial year 2023
![AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2023http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbEFDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--507b344b1f20eff6a87ec7cc44acfa0f3e7ed125/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aevis-logo.png?locale=de)
AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2023
EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR
![Why Medical Properties Trust Stock Popped Today: https://g.foolcdn.com/editorial/images/770930/rent-blocks-real-estate-rental.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEpqYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--99171a95d1417e765367a807abe3d228a52cb2af/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/rent-blocks-real-estate-rental.jpg?locale=de)
Why Medical Properties Trust Stock Popped Today
Shares of Medical Properties Trust (NYSE: MPW) soared 18.6% on Wednesday after the largest tenant of the healthcare facilities-focused real estate investment trust (REIT) announced a deal to sell
![Tufts Medicine and Acadia Healthcare Break Ground on New Behavioral Health Hospital to Serve the Greater Boston Area: https://mms.businesswire.com/media/20240327491580/en/2082072/5/ACHCTuftsphoto.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNzFpYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5fbd166ae260c115607e2223af8af64d4740ec8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ACHCTuftsphoto.jpg?locale=de)
Tufts Medicine and Acadia Healthcare Break Ground on New Behavioral Health Hospital to Serve the Greater Boston Area
Tufts Medicine, a leading Massachusetts integrated, academic health system, and Acadia Healthcare Company, the largest standalone provider of behavioral health services in the U.S., today held a
![Why Illumina Stock Zoomed Higher on Thursday: https://g.foolcdn.com/editorial/images/770227/medical-professional-working-at-a-computer-terminal.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXRkYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b796823963566c1ce10d8ed21676fcd2f5187324/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/medical-professional-working-at-a-computer-terminal.jpg?locale=de)
Why Illumina Stock Zoomed Higher on Thursday
A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P
![Bull Market and Beyond: 2 Stocks to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/769484/doctor-smiling-and-holding-patients-hand.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNFZjYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9444f6f68354e976c82a64e211a7230d17e44730/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/doctor-smiling-and-holding-patients-hand.jpg?locale=de)
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
Investors are enjoying the ongoing bull run. The S&P 500 and Nasdaq Composite recently hit all-time highs. Though that's pretty exciting, bull markets don't last forever. Equities that can perform
EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
![AEVIS VICTORIA SA (AEVS.SW) – Publication of the 2023 revenuehttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbEFDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--507b344b1f20eff6a87ec7cc44acfa0f3e7ed125/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aevis-logo.png?locale=de)
AEVIS VICTORIA SA (AEVS.SW) – Publication of the 2023 revenue
![Humana and DUOS Launch Groundbreaking Initiative Enhancing Care for U.S. Veteran Seniors: https://mms.businesswire.com/media/20240320863840/en/2072794/5/2022_HUMANA_C2-Day3-SC12-2_Single-Single-Porch_0054_AQ1_original.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenhiYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d96ebf80d4853fc7874e2cac8e2ae12bc30f743c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/2022_HUMANA_C2-Day3-SC12-2_Single-Single-Porch_0054_AQ1_original.jpg?locale=de)
Humana and DUOS Launch Groundbreaking Initiative Enhancing Care for U.S. Veteran Seniors
Humana Inc. (NYSE: HUM) and DUOS, a technology-enabled service provider announces a new collaborative program to enhance the healthcare experience and improve health outcomes for Louisiana Veteran
![STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses: https://mms.businesswire.com/media/20240318771746/en/2069563/5/EVO_-_3M_Lens_commas.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd1pZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c3ace4cb48c8146a112d6823177d7f8b07f2166c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/EVO_-_3M_Lens_commas.jpg?locale=de)
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today
![How Rivian Can Not Only Survive but Thrive in 2024: https://g.foolcdn.com/editorial/images/768963/rivian_introduces_its_midsize_platform_family.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMVJYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8bd4695180e4ae0dd70aa9b462af081b443be8b3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/rivian_introduces_its_midsize_platform_family.jpg?locale=de)
How Rivian Can Not Only Survive but Thrive in 2024
A storm has been brewing around the electric vehicle (EV) industry. The storm is a mix of high interest rates that make consumers hesitant to purchase vehicles, charging infrastructure challenges, a
![Is Rithm Capital Stock a Buy?: https://g.foolcdn.com/editorial/images/768660/stock-trading-person-getty-2022.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeUZXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0528932c028164fecd945e9260fde96a520a6c36/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/stock-trading-person-getty-2022.jpg?locale=de)
Is Rithm Capital Stock a Buy?
Dividend stocks can be an excellent source of passive income, and Rithm Capital (NYSE: RITM) is one of the highest-yielding dividend stocks you can buy today. Its 9.1% dividend yield makes it an
![Rivian Automotive Stock Has Nearly 100% Upside, According to 1 Wall Street Analyst: https://g.foolcdn.com/editorial/images/769426/rivian-r1t-is-rivian.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeVZXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ab7561ed5a53da53c427d8f68078b6b1dd2b2cd8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/rivian-r1t-is-rivian.jpg?locale=de)
Rivian Automotive Stock Has Nearly 100% Upside, According to 1 Wall Street Analyst
Rivian Automotive (NASDAQ: RIVN) investors had a traumatic Thursday, as news of rival Fisker's probable restructuring sent electric car investors scurrying for cover. However, no sooner had markets
![1 Wall Street Analyst Warns That Rivian Stock Could Drop to $9: https://g.foolcdn.com/editorial/images/768901/rivian-r1t-is-rivian.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNTlTYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2542fa77f1697cb52c185de871b7f128767d6eba/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/rivian-r1t-is-rivian.jpg?locale=de)
1 Wall Street Analyst Warns That Rivian Stock Could Drop to $9
Last week, Rivian Automotive (NASDAQ: RIVN) unveiled not one, but two new prospective electric vehicles: The slimmed-down R2 electric SUV and an unexpected R3 electric hatchback. But investor
![AEVIS VICTORIA SA - Fabrice Zumbrunnen to become CEO of AEVIS VICTORIA SA as of May 1, 2024http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbEFDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--507b344b1f20eff6a87ec7cc44acfa0f3e7ed125/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aevis-logo.png?locale=de)
AEVIS VICTORIA SA - Fabrice Zumbrunnen to become CEO of AEVIS VICTORIA SA as of May 1, 2024
![2 Medical Device Stocks to Buy Hand Over Fist in March: https://g.foolcdn.com/editorial/images/768037/medical-professional-smiling.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWhPYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dc69de3bb659f245cf17e5331ed0814a40e77e5a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/medical-professional-smiling.jpg?locale=de)
2 Medical Device Stocks to Buy Hand Over Fist in March
A good way to invest in the healthcare industry's continued growth is by targeting businesses that make medical devices. Such equipment aids physicians in surgery, helps patients recover, and can
![Rivian Exposed: R2 Launch Shows Big Problems: https://g.foolcdn.com/editorial/images/768501/240302_elliot_ross_2880x1920_4.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnBPYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ed0dafd5488808da3a8c17c53f3df713ad0db692/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/240302_elliot_ross_2880x1920_4.jpg?locale=de)
Rivian Exposed: R2 Launch Shows Big Problems
Rivian's (NASDAQ: RIVN) biggest challenge right now is cash. The company's cash burn is unsustainable while building out R2 and R3 capacity, which is why management announced reduced capital